[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"liver-metastases-from-colorectal-cancer-mcrc\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:liver-metastases-from-colorectal-cancer-mcrc":46},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":27,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100513567",false,"NCT05967143","Observational SIR-Spheres Study for the Treatment of Unresectable Liver Tumors (SIRtain Registry)","Observational Study to Assess Real-World Outcomes in Patients With Unresectable Liver Tumors Initiating Treatment With SIR-Spheres (Y-90 Resin Microspheres) (SIRtain Registry)","SIRtain","Inclusion Criteria:\n\n* Age 18 years or older\n* Confirmed diagnosis of:\n* Unresectable hepatocellular carcinoma (HCC) Or\n* Unresectable liver metastases from colorectal cancer (mCRC) refractory to or intolerant to chemotherapy\n* Identified as a candidate for SIR-Spheres treatment as deemed appropriate during the normal course of practice\n* Planned to receive SIR-Spheres treatment to the liver for the first time\n* Provision of signed patient informed consent\n\nExclusion Criteria:\n\n* Prior radiation treatment to the liver\n\nCaveat:\n\nSequential selective internal radiation therapy (SIRT) treatment is allowed\n\n* Patients participating in any interventional clinical trial with an investigational product, device, or procedure\n* Need for surrogate consent. Patients who are not able to consent on behalf of themselves are not eligible.","ALL","18 Years",{"count":19,"type":20},845,"ESTIMATED","2 Years","OBSERVATIONAL","This registry seeks to prospectively gather a large repository of comprehensive observational data reflecting routine use of SIR-Spheres in patients diagnosed with unresectable HCC or unresectable liver metastases from mCRC refractory to or intolerant to chemotherapy, in order to assess clinical response in a real-world setting and further validate the safe and appropriate use of SIR-Spheres",[25,26],"Unresectable Hepatocellular Carcinoma (HCC)","Liver Metastases From Colorectal Cancer (mCRC)",[28,29,30,31,32],"Liver metastases from colorectal cancer (mCRC)","Unresectable Hepatocellular carcinoma (HCC)","SIR-Spheres microspheres","Y-90 resin microspheres","SIRT","RECRUITING","2024-11-26",{"date":36,"type":37},"2024-11-27","ACTUAL",{"date":39,"type":37},"2023-06-19",{"date":41,"type":20},"2029-06",{"name":43,"class":44},"Sirtex Medical","INDUSTRY",9,""]